COMMUNIQUÉS West-GlobeNewswire

Chimerix to Announce First Quarter 2018 Financial Results on May 7, 2018
30/04/2018
DURHAM, N.C., April 30, 2018 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ: CMRX ), a biopharmaceutical company developing novel antivirals for the growing population of immunocompromised patients, today announced that it will [...]
Keryx Biopharmaceuticals Announces Changes to Management and Preliminary First Quarter 2018 Revenue
30/04/2018
Gregory Madison resigned as president and chief executive officer of the company and from its board of directors Jodie Morrison, current Keryx board member, named interim chief executive officer Company expects to [...]
Sirona Biochem to Exhibit at the Shanghai China Beauty Expo 2018
30/04/2018
VANCOUVER, British Columbia, April 30, 2018 (GLOBE NEWSWIRE) -- Sirona Biochem Corp . (TSX-V: SBM ) (FSE:ZSB) (the “ Company ”) announced today that they will be exhibitors at China Beauty Expo (CBE) 2018. The trade [...]
International Endeavors Corporation, a Medical Marijuana IP Holdings Company today announces the introduction of OGGL, OFF-GRID GROW LAB
30/04/2018
TEMECULA, Calif., April 30, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- International Endeavors Corporation (OTC:IDVV) is pleased to announce that After the appointment of new board member Andrew Read earlier this year [...]
Daré Bioscience announces funding award to further the development of Ovaprene™ from the National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
30/04/2018
SAN DIEGO, April 30, 2018 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE ), a clinical-stage, women’s biopharmaceutical company, today announced that it received a Notice of Award for the first $224,665 of the [...]
Orion has completed the sale of Orion Diagnostica business division
30/04/2018
ORION CORPORATION PRESS RELEASE 30 April 2018 at 12.15 p.m. Orion has completed the sale of Orion Diagnostica business division Orion Corporation has completed the sale of all shares in Orion Diagnostica Oy (i.e. the [...]
Election of the Board of Directors on the annual general meeting
30/04/2018
Company announcement 30 April 2018 On 27 April 2018, NeuroSearch A/S ("NeuroSearch") received a notice from Gefion Group Investments A/S ("Gefion") that Gefion had decided to launch a conditional, voluntary takeover [...]
Transactions under Novozymes’ stock buyback program
30/04/2018
Please read the full announcement in the attached PDF Attachment 2018_19_Stock_Buybackprogram_EN
Trading by management and close relations of management
30/04/2018
Read the full announcement in the attached file Attachment 2018_18_Trading_by_management_EN
Changes to Biohit Oyj’s Management Team
30/04/2018
Biohit Oyj, Stock exchange release, April 30, 2018 at 11:00 am local time (EET) M.Sc. (Econ) Jukka Kainulainen (b. 1982) has been appointed Chief Financial Officer and as a member of the Management Team of Biohit Oyj [...]
Curetis Announces Change of the Composition of Its Supervisory Board
30/04/2018
Curetis Announces Change of the Composition of Its Supervisory Board Dr. Holger Reithinger resigns as member of the Supervisory Board Company exploring options to further evolve Board at upcoming 2018 AGM Amsterdam, the [...]
ABLYNX ANNOUNCES WARRANT EXERCISE
30/04/2018
REGULATED INFORMATION GHENT, Belgium, 30 April 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in conformity with Title II of the Law of 2 May 2007 and the Royal Decree of 14 February 2008, that an [...]
PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")
30/04/2018
REGULATED INFORMATION GHENT, Belgium, 30 April 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]
Sanofi: FDA to Conduct Priority Review of Cemiplimab as a Potential Treatment for Advanced Cutaneous Squamous Cell Carcinoma
30/04/2018
Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) FDA to Conduct Priority Review of Cemiplimab as a Potential Treatment for Advanced Cutaneous Squamous Cell Carcinoma Paris and Tarrytown, NY - April 30, 2018 - [...]
Sanofi : FDA accorde un examen prioritaire au cemiplimab dans le traitement potentiel du carcinome épidermoïde cutané au stade avancé
30/04/2018
Communiqué de presse Source : Sanofi (EURONEXT : SAN) (NYSE : SNY) FDA accorde un examen prioritaire au cemiplimab dans le traitement potentiel du carcinome épidermoïde cutané au stade avancé Paris et Tarrytown (New [...]
Addex Reports 2017 Full Year Results and Provides Corporate Update
30/04/2018
Robust cash position of CHF45 million following capital raise in Q1 2018 Major global licensing agreement with Indivior in addiction Geneva, Switzerland, 30 April 2018 - Addex Therapeutics (SIX: ADXN), a leading company [...]
Innate Pharma to hold its AGM on May 29, 2018 and the release of its Reference document
30/04/2018
Innate pharma TO hold ITS annual general meeting of shareholders on May 29, 2018 and THE RELEASE OF ITS REFERENCE DOCUMENT (IN FRENCH) Marseille, France, April 30, 2018 Innate Pharma (the "Company" - Euronext Paris: [...]
Innate Pharma annonce la tenue de son AG annuelle le 29 mai 2018 et la mise à disposition de son DDR 2017
30/04/2018
INNATE PHARMA ANNONCE LA TENUE DE SON ASSEMBLEE GENERALE ANNUELLE LE 29 MAI 2018 A MARSEILLE ET LA MISE A DISPOSITION DE SON DOCUMENT DE REFERENCE 2017 Marseille, le 30 avril 2018 Innate Pharma (Euronext Paris : [...]
ABLYNX COMPLETES PATIENT RECRUITMENT IN THE PHASE IIb RESPIRE STUDY OF ITS INHALED ANTI-RSV NANOBODY ALX-0171
30/04/2018
REGULATED INFORMATION - INSIDE INFORMATION GHENT, Belgium, 30 April 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced that it has successfully completed patient recruitment in the Phase IIb RESPIRE dose [...]

Pages